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 SUPPLEMENTARY FIGURES AND TABLES 
  
Figure S1. Study design. Number of investigated SNPs, genotyping platforms, and study 
sample characteristics are shown by cohort for EGCUT, ERF, KORA F4, KORCULA, 
MICROS, NESDA, and ORCADES. Stage-1 and Stage-2 refer to discovery and replication 
phases, respectively. Plots refer to the distributions of chronotype (mid-sleep phase on free-
days adjusted for the sleep deficit accumulated during the work-week and normalized for age 
and sex – MSFsasc) and average sleep duration (SDav). IND = individuals. 
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Figure S2. Study-specific and meta-analysis quantile-quantile plots. Quantile–quantile plots 
and lambda (λ) values were estimated for the primary analysis using the Cochran–Armitage 
trend test and for the confirmatory analyzes using logistic regressions and Cochran–Mantel–
Haenszel stratified tests. Shown are expected P-values plotted against observed P-values 
resulting from each single study and for the meta-analysis after genomic control correction. 
All cohorts showed low over-dispersion of the chi-square statistics with the following λ-
values: EGCUT = 1.00, ERF = 0.99, KORA F4 = 1.01, KORCULA = 0.97, MICROS = 0.99, 
NESDA = 0.99, and ORKNEY = 1.03. For the overall meta-analysis, the inflation factor (λ) 
was 0.997. If λ is large (for example, > 1.2), there is evidence that the observed test statistics 
deviate from the expected. This could be due to true associations but is more likely due to a 
systematic bias (for example, population stratification effects). Filled circles indicate observed 
association above expected (red line).  





Figure S3. Manhattan plot of the meta-analysis. SNPs are plotted on the x-axis according to 
their position on each chromosome against associations with sleep duration on the y-axis 
(shown as –log10 P). The locus associated with sleep duration (P < 5 x 10−8) in the meta-












Figure S4. Top 100 association signals in the meta-analysis (top panel) with their respective 
Rsq (a quality measure that indicates how reliable the imputation is for each SNP; bottom 
panel) per GWAS. SNPs are order by chromosomal location, as indicated in the rectangles 
above the Rsq values. To filter imputed data we combined a minor allele frequency threshold 
with either the imputed information score < 0.3 (Proper_Info in IMPUTE; NESDA cohort) or 
the variance ratio < 0.3 (rsq_hat in MACH; other cohorts), for details see Supplementary 
Table 3. A large variation in imputation quality was observed across platforms mostly for 
SNPs on the chromosomes, 5, 7 – 11, 15 and 18; none of which were among the top 10 loci 
we report in Table 1. Only 13% of the 100 top association signals came from SNPs genotyped 
in at least one of the independent GWAS. 
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Figure S5. Genomic positions of SNPs within the ABCC9 region (NCBI build 36, UCSC 
hg18, chr12:21683593−22083593). The top panel shows SNP single marker association 
results (significances as -log10 of nominal P), and all known genes and predicted transcripts in 
the local area. The bottom panel shows the LD structure of the same region. Boxes are shaded 
(from white to black) according to the disequilibrium coefficient based on r2 (from weak to 
perfect LD). The top ranking SNP (rs11046205 – diamond in the top and bottom panels) 
presents moderate LD (0.8 > r2 > 0.5) with only two other SNPs (rs12425757, rs1517284; in 
green). The second best hit (rs11046211) in this locus has 6 other SNPs in perfect LD with it 
(marked in blue in the bottom panel). Recombination rates in centimorgans (cM) per 
megabase (Mb) are indicated at the base of the graphic (blue line). 




Figure S6. Forest plots for 8 SNPs from the ABCC9 locus that were among the best 100 
associations in the meta-analysis. Contributing effects from each study are represented by 
squares, with confidence intervals indicated by horizontal lines. The contributing weight of 
each study to the meta-analysis is indicated by the size of the squares. The diamond at the 
bottom of each graph represents the meta-analysis pooled estimate. Significance is achieved 
at the set level if the diamond is clear of the line of no effect (vertical dashed line). 
rs11046205 reached GWA significance (P = 3.6 x 10-8). rs11046206, rs11046207, 
rs11046209, rs12369421, rs12371172, and rs2307026 are proxies of rs11046211 
(P = 9.90 x 10-6) and had very similar P-values (1 x 10-5 to 1.5 x 10-5).  




Figure S7. Forest plots for 8 SNPs that were among the best ranking loci on the meta-
analysis. Contributing effects (beta) from each study are represented by squares, with 
confidence intervals indicated by horizontal lines. The contributing weight of each study to 
the meta-analysis is indicated by the size of the squares. The diamond at the bottom of each 
graph represents the meta-analysis pooled estimate. Significance is achieved at the set level if 
the diamond is clear of the line of no effect (vertical dashed line). Plots are ordered by 
chromosome SNP position. Except for rs2245601 (at the coding region of the cholinergic 
receptor delta subunit – CHRND locus), all SNPs showed consistent effect directions in the 
discovery phase. None of the P-values were significant at the genome-wide level (for details 
see Table 1). 
 
 




Figure S8. The top panel shows a regional plot of the CLOCK gene (500 kb up- and 
downstream of rs12649507, earlier associated with SDav1) for associations with SDav in the 
discovery meta-analysis (−log10 P values on the y axis and the SNP genomic position on the 
x axis). We could confirm the earlier association of rs12649507 or rs11932595 with SDav 
(only had imputed genotypes) in the larger MICROS sample investigated here, but not in 
other cohorts. The low-quality imputation in the region also could not support multi-marker 
analysis in the present GWAS and might explain why we did not replicate it in the EGCUT 
samples – also used in the earlier candidate study.1 We detected in the discovery meta-
analysis other modest association signals in SNPs surrounding this locus (see Table 6). SNPs 
are coloured according to the disequilibrium coefficient based on r2 (from weak to perfect 
LD). The bottom panel shows clock genes showing associations (P < 0.05; within 20, 100, or 
500 kb up- and downstream of the genes) with SDav in our discovery phase meta-analysis. 
CSNK1A1 is the gene with the best ranking SNPs.  




Figure S9. (A) Average of mean day and (B) night sleep amount, over two days, for the UAS-
Sur RNAi knockout lines (black bars) and controls (gray bars). Sleep duration of knockout 
UAS-Sur lines was clearly reduced in the night phase compared to controls. During the day, 
the V6750 insertion control slept significantly more than the V6750 knockdown, indicating 
that there is no daytime compensation for loss of nighttime sleep. CS control flies slept on 
average longer than any other strain during the night, while HU control flies slept shorter than 
any other strain during the day. Error bars are standard errors of the means. Stars represent 
that significant differences were found in relation to other genotypes by one-way ANOVA.  
 

























Figure S10. Free-running periods of the experimental knockdown lines and the GAL4 driver 
control. There were no significant differences in free-running period between the 
experimental knockdown lines and the GAL4 driver control were observed (F 2,60 = 1.49, 
P = 0.23).  These periods were very similar to those obtained from repeated analyses for the 
domesticated Canton-S and various wild strains.2 Error bars are standard errors of the means. 





Figure S11. Mean waking locomotor activity of experimental and controls flies during the 
light (day; panel A) and dark (night; panel B) phases averaged over 2 days. Error bars are 
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Table S1. Study sample characteristics. Sample size, age, BMI, and sleep duration means per gender are shown by cohort for EGCUT, ERF, KORA 















Data set (Ethnicity) 
Sample size Mean age y. (range) Mean BMI ± SD Mean sleep duration ± SD 
total females (males) females males females males females males 
EGCUT (Estonian) 924 518 (406) 41.0 (18 - 86) 38.2 (18 - 82) 25.6 ± 5.8 25.7 ± 4.6 7.92 ± 1.11 7.83 ± 1.14 
ERF (Dutch) 740 397 (343) 46.7 (19 - 75) 50.0 (20 - 75) 25.8 ± 4.69 27.3 ± 4.21 7.57 ± 1.10 7.26 ± 0.95 
KORA F4 (German) 548 279 (269) 54.6 (40 – 65) 55.3 (36 – 66) 26.6 ± 0.87 27.8 ± 4.21 7.30 ± 0.87 7.20 ± 0.81 
KORCULA (Croatian) 600 383 (217) 55.6 (18 - 75) 57.3 (22 - 76) 27.8 ± 4.37 28.8 ± 3.56 7.34 ± 1.25 7.41 ± 1.14 
MICROS (Italian) 693 374 (319) 39.3 (10 - 75) 41.1 (10 - 75) 24.2 ± 4.73 25.6 ± 4.04 8.20 ± 0.83 7.90 ± 1.07 
NESDA (Dutch) 540 358 (182) 39.8 (18 - 66) 44.2 (19 - 65) 24.8 ± 5.00 26.0 ± 4.50 7.50 ± 0.90 7.80 ± 1.00 
ORCADES (Scottish) 206 116 (90) 49.8 (18 - 73) 50.0 (17 - 71) 26.8 ± 5.13 26.7 ± 3.48 7.54 ± 0.88 7.26 ± 0.88 
EGCUT in silico 536 250 (286) 38.9 (18 - 83) 39.6 (18 - 84) 24.2 ± 4.62 25.53 ± 3.93 7.98 ± 1.07 7.89 ± 1.02 
EGCUT de novo total 5 949 3 006 (2 943) 39.1 (18 - 55) 34.0 (17 - 55) 25.4 ± 5.2 26.0 ± 5.0 7.93 ± 0.89 8.00 ± 1.00 
Summer 3 226 1 654 (1 572) 39.1 (18 - 55) 33.2 (17 - 55) 25.2 ± 5.1 25.7 ± 4.4 7.89 ± 0.89 7.89 ± 0.97 
Winter 2 645 1 312 (1 333) 38.9 (18 - 55) 34.4 (17 - 55) 25.5 ± 5.2 26.0 ± 4.7 7.96 ± 0.89 7.89 ± 0.97 
Winter early chronotype 1 322 624 (698) 38.7 (19 - 55) 34.3 (17 -55) 25.8 ± 5.3 26.01 ± 4.6 8.01 ± 0.87 7.94 ± 0.99 
Winter late chronotypes 1 323 688 (635) 39.1 (18 - 55) 34.5 (18 -55) 25.36 ± 5.1 26.05 ± 4.8 7.93 ± 0.90 7.80 ± 0.95 
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Table S2. Pharmacological sleep agents. Drug groups and correspondent ATC codes used as exclusion criteria when selecting phenotyped subjects 
for the independent GWA studies a. 
Drug groups Pharmacological ATC codes 
Benzodiazepines N05CD, N05CF 
Barbiturates  N01AF, N01AG, N03AA, N05CA, N05CB, N05CX 
Imipramine N06AA02, N06AA03, N06AA06  
Nortriptyline N06AA10 
Neuroleptics N05AK 
Phenothiazines N05AB, N05AC, N05AA 
Fluoxetine N06AB03  
Sertraline N06AB06 
Paroxetine N06AB05 
ß-Blockers, propranolol C07, S01ED 
Theophylline R03DA04 
Amphetamine  N06B  
a
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Table S3. Stage-1 genotyping and imputation details across the different platforms used.  
a For the cohorts ERF and MICROS a linear mixed model3 in ProbABEL was used to account for familial relationships. The software incorporates the FASTA method4 and kinship 
matrix5 estimated from the genotyped SNPs to correct for relatedness. For KORCULA and ORCADES, the first three principal components were used as covariates in the model to 
adjust for relationships. All individual studies association results underwent genomic control before meta-analysis. Other cohorts were comprised of unrelated individuals (EGCUT, 
KORA, and NESDA). MAF: minor allele frequency. Imputation error can very between platforms generating false negative and false positive findings, but several quality control 
criteria as allele frequency, Hardy-Weinberg equilibrium (HWE), effect direction and association signals for correlated SNPs will help to filter out false positive findings.6 We may miss 














Total of SNPs 
for imputation  





imputed HWE    
P 
Call rate 




EGCUT Illumina 370K 10-6 98% 95% 0.01 MACH 1.0.16 36 ProbABEL 310 000 2 412 810 87.2 
ERF Illumina 6K, 318K, 370K, Affymetrix 250K 10
-6
 95% 95% 0.01 MACH 1.0.16 36 ProbABEL up to 487 573 2 408720 
79.8 
KORA Affymetrix 1000K 10-5 95% 95% 0.01 MACH 1.0.16 36 ProbABEL 688 765 2 442 744 71.8 
KORCULA Illumina 370K 10-10 98% 98% 0.02 MACH 1.0.15 36 ProbABEL 30 7728 2 369 235 87.0 
MICROS Illumina 318K 10-6 98% 98% 0.01 MACH 1.0.16 36 ProbABEL 292 917 2 375 117 87.7 
NESDA Perlegen 600K - 95% 95% 0.01 IMPUTE 1.0 35 SNPTEST 435 291 2 403 506 81.9 
ORCADES Illumina 318K 10-10 98% 98% 0.02 MACH 1.0.15 36 ProbABEL 306 207 2 402 555 87.3 
EGCUT in silico 370CNV-quad 10-6 98% 95% 0.01 IMPUTE 1.0 36 SNPTEST 188 000 2 412 810 92.2 
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Table S4. TaqMan genotyping efficiency and association results for the meta-analysis top hit (rs11046205) in 3 discovery cohorts that only had 
imputed genotypes for this SNP.  
The genotyped variants were in Hardy-Weinberg equilibrium (P > 0.05) in all cohorts. a KORCULA genotypes concordance maybe lower than for other cohorts because of 












call rate (SNP) 
Imputed / genotyped data 
Sample N Beta  P-values Combined P (meta) 







3.68 x 10-8 /  
3.99 x 10-8 KORA 0.185 0.185 87% 96% 548 / 527 




KORCULA 0.189 0.195 to 0.196 68% a 96% 600 / 584  0.1779 / 0.0387 0.07 / 0.9 




Table S5. List of best 100 associations with SDav in our discovery meta-analysis. The file 
included SNP rs codes, genomic position, alleles, variant role, gene, effect (beta), P-values, 
effect direction across cohorts, and a list of genes with altered expression associated with the 
respective SNPs. To be downloaded as a separate excel file. 
 
Table S6. List of associations (P < 0.05) found in 19 clock genes (within 100 KB up- or 
downstream of these genes) with SDav in our discovery meta-analysis. The file included SNP rs 
codes, alleles, effect (beta), P-values, effect direction across cohorts, and genomic positions. To 
be downloaded as a separate excel file. 
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Table S7. Independent Sample Mann-Whitney U-test. 
Dependent variable: SDasc  N SDasc ± SEM Mean rank Sig. 
Grouping by season (Summer / Winter)     
EGCUT 361 / 563 924 7.84 ± 0.07 456  / 563 0.759 
KORA 288 / 260 548 7.64 ± 0.06 262 / 287 0.061 
KORCULA 335 / 291 626 7.50 ± 0.06 307 / 321 0.302 
MICROS 284 / 379 663 8.18 ± 0.06 323 / 339 0.285 
ORCADES 212 / 218 430 7.56 ± 0.07 207 / 224 0.167 
EGCUT replication 3 226 / 2 645 5 871 8.10 ± 0.02 2886 / 2997 0.012* 
EGCUT in silico 365 / 171 536 7.95 ± 0.06 272 / 260 0.390 
Grouping by chronotype (1st early / 2nd late half) 
EGCUT 
 
Summer 181 / 180 361 7.84 ± 0.12  172 / 189 0.123 
Winter 282 / 281 563 7.83 ± 0.90 286 / 277 0.507 
KORA Summer 145 / 143 288 7.58 ± 0.05  143 / 146 0.692 
Winter 130 / 130 260 7.70 ± 0.05  129 / 231 0.817 
KORCULA Summer 168 / 167 335 7.45 ± 0.06  181 / 155 0.012* 
Winter 146 / 145 291 7.56 ± 0.07  153 / 138 0.124 
MICROS Summer 141 /142 283 8.14 ± 0.05  145 / 138 0.477 
 Winter 189 / 190 379 8.20 ± 0.04  207 / 172 0.002** 
ORCADES Summer 106 /106 212 7.51 ± 0.06  108 / 105 0.694 
 Winter 109 / 109 218 7.61 ± 0.05 107 / 112 0.497 
EGCUT replication Summer 1613 / 1613 3 226 8.08 ± 0.01 1 683 / 1 544 2.1 x 10-5*** 
 Winter 1322 / 1323 2 645 8.12 ± 0.01 1 375 / 1 271 4.9 x 10-4*** 
EGCUT in silico Summer 183 / 182 365 7.98 ± 0.05  193 / 172 0.056 
 Winter 86 / 85 171 7.89 ± 0.79 84 / 88 0.621 
The total N of individuals assessed here was dependent of the availability of the dates of the assessments. Some 
of the populations had a slightly larger sample for the phenotype analyses than for the GWAS analyses. Data 
from ERF and NESDA were not available. Summer: defined as the period of the respective year with day-light 
saving time – DST. Winter: defined as the period without DST. SDasc = average sleep duration normalized for 
age and sex. SEM = standard error of the mean. Stars represent that significant differences in SDasc were found 
between subgroups of the population. 
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Table S8. In silico and de novo genotyping replication samples association results versus 
discovery phase meta-analysis results for the ABCC9 SNPs.  
EGCUT replication ABCC9 SNPs (Chr 12) 
Effect 






Summer / Winter 
Av sleep duration 
rs11046205 
 
A 3 219 / 2 644 










T 3 203/ 2 682 
-0.015/ 
0.014  








A 3 209/ 2 681  
0.009 /      
- 0.006  








Winter Av sleep 
duration: 
1st half (early) / 





A 1 321 / 1323 










T 1 309 / 1 322 










A 1 313 / 
1 313 








In silico total 
rs11046205 
 
A 53 0.047 0.082 0.568 0.1565 (0.028) 
rs11046211 
 
T 536 0.055 0.100 0.585 0.2001 (0.045) 
rs11046209 
 
A 536 -0.059 0.099 0.551 -0.1951 (0.045) 
All SNPs were in HWE, had minor allele frequency > 0.05, and the call rate per individual was > 98%. P-values 
significance threshold was P ≤ 0.05. SEM = standard error of the mean. Summer: defined as the period of the 
respective year with day-light saving time – DST. Winter: defined as the period without DST. Av sleep duration 
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Table S9. Meta-analyzes results for rs11046205 (ABCC9). Meta-analyzes of discovery cohorts, 
before and after de novo genotyping, and meta-analysis of the discovery and replication results.  
a
 Including 3 de novo genotyped cohorts (KORA-EGCUT-KORCULA). W_Early = early chonotypes half of the 
replication dataset collected during the wintertime. 
rs11046205 (effect allele A) N beta beta_95L beta_95U P 
Discovery meta 4 251 0.1669 0.1076 0.2261 3.44 x 10-8 
Discovery meta with KORA-EGCUT de 
novo genotyped 
4 251 0.1715 0.1150 0.2280 2.78 x 10-9 
Discovery meta with KORA-EGCUT-
KORCULA de novo genotyped 
4 251 0.1565 0.1007 0.2123 3.99 x 10-8 
Discovery meta a, in silico and de novo 
W_Early replication 
6 045 0.1234 0.0784 0.1685 7.94 x 10-8 
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SUPPLEMENTARY MATERIALS AND METHODS 
 
Description of the discovery phase study cohorts 
1) The EGCUT is a bio-bank consisting of data of 40 000 individuals from a population based 
Estonian cohort.7 GWAS was performed on 924 phenotyped subjects (56% females). The 
cohort consisted of two sets of samples: i) 480 population based samples which are part of a 
bigger study and were selected randomly from all over the country and ii) 444 individuals 
selected as tails from the corrected chronotype distribution (assessed with the Munich 
ChronoType Questionnaire) of 5 098 individuals (mid-sleep values normalized for age and 
gender were 0.55-2.55 and 5.75-9.12). SDav had a continuous and approximated to normal 
distribution for this GWA sample.  
2) ERF is a family-based study that includes over 3 000 participants descending from 22 
couples living in the Rucphen region in the 19th century.8 All living descendants of these 
couples and their spouses were invited to take part in the study. 1 700 individuals from this 
population were assessed for sleep duration (see phenotyping for details). After strict 
phenotype quality control only 940 respondents were available for the analysis, of which 740 
individuals (54% females) were used in the genome-wide analysis.9  
3) The KORA F4 research project has evolved from the WHO MONICA study (Monitoring 
of Trends and Determinants of Cardiovascular Disease). The KORA genome-wide 
association study was done using samples from the KORA S4 survey,10 which is a 
population-based sample from the general population living in the region of Augsburg, 
Southern Germany. Samples were recruited between 1999-2002 independent from KORA S3 
but using the same platform with the same standard operating procedures and based on the 
same population. KORA F4 is part of this sample (with a 10-year follow-up) and 1 814 
subjects were genome-wide genotyped. All participants had a German passport and were of 
European origin. Apart from the standard phenotype exclusion criteria, we excluded subjects 
Running title: ABCC9 regulates sleep duration Karla V. Allebrandt et al. 
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older than 65 years old. In total, 548 (51% females) individuals who passed phenotype and 
genotype quality control could be included in the GWA analysis.  
4) KORCULA is a family-based, cross-sectional study on the Dalmatian island of Korcula. 
600 subjects (64% females) who passed phenotype and genotype quality control were used 
for the GWA analysis.11  
5) MICROS is a family-based study that is part of the genomic health care program 
'GenNova'. It was carried out in three villages of the Val Venosta, South Tyrol (Italy), in 
2001-2003.12 740 subjects (54% females) who passed phenotype and genotype quality control 
were included in the GWA analysis.  
6) The NESDA study consists of 2 981 unrelated persons including both major depressive 
disorder cases as well as healthy controls without a history of major depressive disorder.13 
540 healthy controls (66% females) without current or prior major depressive disorder, who 
passed phenotype and genotype quality control, were used for the GWA analysis.  
7) ORCADES is a family-based collection from an isolated Scottish population. Genetic 
diversity is decreased compared to the mainland Scottish samples, consistent with a high 
extent of endogamy. The current study included 206 individuals (56% females) who passed 
phenotype and genotype quality control.  
 
Characterisation of Drosophila knockdown 
Males from the w1118 ;  V6750; + RNAi line was crossed to w1118 ; +;  Actin>GAL4 / TM6B, 
Tb1 females that carry a driver active in all tissues, so that in the F1 generation, flies carrying 
the TM6B,Tb1  chromosome represented control non-expressing siblings of the knock-down 
flies (that carry Actin>GAL4). Total RNA was extracted from three biological replicates of 
two males and two females of each genotype using a column based kit (Norgen Biotek Corp).  
The qPCR reaction was performed using a Brilliant II 1-step qPCR kit (Agilent Technologies) 
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using 50ng of total RNA following the manufacturer’s instructions on a LightCycler 480 
instrument (Roche Applied Science).  The dSur RNA was amplified with exon spanning 
primers (Forward: acgtggacaatccaagtgaac, Reverse: cgagtgtcctccgtcatgt), and RNA levels 
were calculated relative to the RP49 housekeeping gene using four technical replicates for 
each reaction.  Ratios of target/reference gene were calculated using the LightCycler 480 
software v1.5 (Roche Applied Science), and ratios for knockdown and wild-type sibs were 
compared, giving an estimated gene knockdown of 89% (t = 2.99,  df = 4, P = 0.04). These 
results suggest that the V6750 hairpin construct provided an extremely efficient reduction of 
dSur to very low levels in tissues such as the neuronal cells targeted by the elav>GAL4 driver 
used in this study. 
 
Drosophila behavioural assays to estimate circadian period 
Circadian period was calculated using CLEAN spectral analysis of free running activity 
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